BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 20, 2014
View Archived Issues
Alteration of endothelial gene methylation patterns underlies atherosclerotic damage
Read More
Preclinical data on novel anti-human CCR9 MAb for leukemia
Read More
Covance to conduct phase I/II study of AM-1030 in atopic dermatitis
Read More
Amgen reports results from second phase III trial of AMG-416 in SHPT
Read More
Novel missense mutation in AR gene responsible for CAIS symptoms
Read More
Novartis invests in Gamida Cell
Read More
Positive phase III results seen with ceftazidime-avibactam in intra-abdominal infections
Read More
Hyaluronidse-2 as potential new marker for platelet activation and IBD
Read More
MediciNova discloses results from phase IIa study of ibudilast in opioid dependence
Read More
Globavir aims to launch combination of approved drugs for Ebola virus infection during 2014
Read More
GlaxoSmithKline describes progress on HCV NS5A Inhibitors
Read More
New CETP inhibitors patented by Chong Kun Dang Holdings
Read More
Acetylon Pharmaceuticals patents novel HD3 inhibitors
Read More
U.S. and Japanese group disclose new FIXa inhibitors
Read More
Chinese researchers synthesize new ALK inhibitors
Read More
Amakem divulges novel ROCK inhibitors
Read More
Cannabis Technologies developing CTI-091 for arthritis and joint disease
Read More
Mount Tam Biotechnologies licenses lupus candidate from Buck Institute
Read More
Phylogica to provide drug discovery services to Genentech
Read More
Evotec to provide compound management for Medicines for MMV's drug discovery initiatives
Read More
Altor BioScience receives NCI grant to support bladder cancer trial
Read More
FDA approves IND for ViaCyte's stem cell therapy for type 1 diabetes
Read More
FDA approves Genzyme's eliglustat for Type 1 Gaucher disease
Read More
Clinigen Group acquires Ethyol from AstraZeneca
Read More
Boehringer Ingelheim files NDA for fixed-dose combination of tiotropium and olodaterol for COPD
Read More
Janssen launches tapentadol for cancer pain in Japan
Read More